The expression of these molecules did not correlate with clinical outcomes, except for PD-1-positive immune cells in tumor nests that correlated with the presence of LN metastasis at diagnosis (p=0.015) (Table 4A). The gene discussed is PDCD1; the disease is neoplasm.